Nirvana Life Sciences Inc. (CSE:NIRV)
Canada · Delayed Price · Currency is CAD 0.1400
+0.1100 (366.67%)
Oct 10, 2025, 5:23 PM EDT
366.67% (1Y)
| Market Cap | 3.20M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -346.30K |
| Shares Out | 22.82M |
| EPS (ttm) | -0.04 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Average Volume | 50 |
| Open | 0.1400 |
| Previous Close | 0.0300 |
| Day's Range | 0.1400 - 0.1400 |
| 52-Week Range | 0.0300 - 0.7500 |
| Beta | 0.22 |
| RSI | 83.63 |
| Earnings Date | Dec 9, 2025 |